Mcp and Diclofenac drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mcp (pectin) and Diclofenac (diclofenac). Common drug interactions include general physical health deterioration among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Mcp and Diclofenac. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Mcp?

Mcp has active ingredients of pectin. eHealthMe is studying from 2,077 Mcp users. Check the latest studies of Mcp.

What is Diclofenac?

Diclofenac has active ingredients of diclofenac. eHealthMe is studying from 41,319 Diclofenac users. Check the latest studies of Diclofenac.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 15, 2026

16 people who take Mcp and Diclofenac together, and have interactions are studied.

What are the common drug interactions of Mcp and Diclofenac, by gender? *:

female:

General physical health deterioration (weak health status)
Neuropathy peripheral (surface nerve damage)
Peripheral vascular disorder
Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
Anaemia (lack of blood)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haemoglobin decreased
Portal hypertensive gastropathy (changes in the mucosa of the stomach in patients with portal hypertension;)
Varices oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach)
Colitis (inflammation of colon)

male:

Diarrhoea
Rash
Urinary tract infection
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
Cutaneous vasculitis (an inflammatory process affecting the vessel wall that leads to its damage)
Drug intolerance (drug sensitivity)
Erectile dysfunction
Retinal vascular disorder (a range of eye diseases that affect the blood vessels in the eye)
Skin lesion

What are the common drug interactions of Mcp and Diclofenac, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Torsade de pointes (a abnormal heart rate with abnormal beating pattern)

40-49:

n/a

50-59:

Cutaneous vasculitis (an inflammatory process affecting the vessel wall that leads to its damage)
Drug intolerance (drug sensitivity)
Erectile dysfunction
Malignant neoplasm progression (cancer tumour came back)
Retinal vascular disorder (a range of eye diseases that affect the blood vessels in the eye)
Skin lesion

60+:

Diarrhoea
General physical health deterioration (weak health status)
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
Varices oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach)
Colitis (inflammation of colon)
Decreased appetite
Duodenal ulcer
Gastrointestinal toxicity (damage to digestive tract by any substance)
Helicobacter gastritis (inflammation of the inner lining of the stomach caused by helicobacter pylori (h. pylori) a bacterium)
Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 6 people, 37.50%
High Blood Pressure: 5 people, 31.25%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 25.00%
Oedema (fluid collection in tissue): 4 people, 25.00%
Tumor: 3 people, 18.75%
Lung Disorder (lung disease): 2 people, 12.50%
Metabolic Disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues): 2 people, 12.50%
Hepatocellular Carcinoma (liver cancer): 2 people, 12.50%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 12.50%
Heart Disease: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Mcp and Diclofenac?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously